Citadel Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $17.1K | Sell |
|
|||||
|
2022
Q4 | $19.7K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $17K | Buy |
|
|||||
|
2022
Q1 | $14K | Sell |
|
|||||
|
2021
Q4 | $59K | Buy |
|
|||||
|
2021
Q3 | $74K | Sell |
|
|||||
|
2021
Q2 | $118K | Buy |
|
|||||
|
2021
Q1 | $110K | Buy |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $121K | Buy |
|
|||||
|
2020
Q1 | $21K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $20K | Buy |
|
|||||
|
2019
Q2 | $11K | Buy |
|
|||||
|
2019
Q1 | $35K | Buy |
|
|||||
|
2018
Q4 | $13K | Sell |
|
|||||
|
2018
Q3 | $31K | Sell |
|
|||||
|
2018
Q2 | $42K | Buy |
|
|||||
|
2018
Q1 | $63K | Buy |
|
|||||
|
2017
Q4 | $41K | Buy |
|
|||||
|
2017
Q3 | $17K | Buy |
|
|||||
|
2017
Q2 | $16K | Buy |
|
|||||
|
2017
Q1 | $17K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $63K | Buy |
|
|||||
|
2016
Q2 | $7K | Buy |
|
|||||
|
2016
Q1 | $12K | Sell |
|
|||||
|
2015
Q4 | $52K | Buy |
|
|||||
|
2015
Q3 | $61K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $178K | Buy |
|
|||||
|
2014
Q3 | $16K | Sell |
|
|||||
|
2014
Q2 | $19K | Buy |
|
|||||
|
2014
Q1 | $1K | Sell |
|
|||||
|
2013
Q4 | $94K | Buy |
|
|||||
|
2013
Q3 | $70K | Buy |
|
|||||
|
2013
Q2 | $13K | Buy |
|